Breaking News on Laboratory Equipment |
All news articles > January 2007
| « Previous month | Next month » |
31-Jan-2007
Pharsight says software makes bioequivalence testing easy
Software provider Pharsight has launched an add-on for its graphical drug modelling method to serve in bioequivalence testing, promising to reduce test failure.
30-Jan-2007
Coley to outsource future drug discovery
After having to abandon a promising experimental hepatitis C vaccine and shedding over a fifth of its workforce, Coley Pharmaceutical has announced it will look to outsource future drug discovery.
29-Jan-2007
Spectroscopy sees through packaging to thwart drug fakers
UK based researchers have added another dimension to anti-counterfeiting with an alternative Raman imaging method that is powerful enough to detect fake drugs without opening the package.
Robotics could speed up stem cell research
Scientists hope to speed up the development of regenerative drugs for diseases such as cancer by using robotics to automate stem cell research.
Puncturing bacteria key to preventing drug resistance
Scientists have today unveiled a technique for tipping the balance in favour of antibiotics in their fight against increasingly drug-resistant 'superbugs'.
26-Jan-2007
Pharma sales fuel Waters resurgence
Waters posted an 11 per cent yearly sales increase on the back of increasing demand from the pharmaceutical industry, generic houses and outsourcing laboratories.
Predicting the relevance of genetic mutations
Scientists have published a website that could aid the quest for personalised medicine by predicting which genetic mutations make an individual susceptible to disease.
PerkinElmer increases R&D spending
Increased research and development (R&D) spending masks strong revenue growth by PerkinElmer's life and analytical sciences division.
24-Jan-2007
Disappointing year for Whatman
In a turbulent year, Whatman has failed to meet its projected revenue target by 1-3 per cent and changed its management but resolved litigation that has been hanging over the firm since 2003.
Animal extremist attacks drop
New legislation has helped curb the number of animal rights extremist attacks with fewer companies succumbing to extremist pressure, according to a UK pharmaceutical industry group.
Test can predict tumour sensitivity to experimental cancer drugs
A new test that predicts if cancer cells are 'primed to die' could be used to guide the development of experimental anti-cancer drugs.
Bruker brings imaging to the masses
Bruker Daltonics has launched a new technology that could accelerate the use of MALDI imaging in drug discovery labs by simplifying sample preparation procedures.
DHL bags Wyeth logistics contract
Shipping giant DHL has bagged a lucrative contract with pharma giant Wyeth and become the first logistics provider to be given complete responsibility for a company's worldwide clinical trial materials distribution.
22-Jan-2007
EU funding made simpler for small business
A simplified template for consortium research agreements funded by the EU should aid small business participation.
Workhorse analytical tools to reduce human errors
Agilent Technologies has signed an agreement with Groton Biosystems to co-market measuring solutions for the pharmaceutical industry, as the Process Analytical Technology (PAT) initiative gains popularity among drug manufacturers constantly looking for ways to improve processing efficiencies and costs.
19-Jan-2007
Competitors fill void left by CodeLink exit
Agilent, Illumina, NimbleGen and Oxford Gene Technology have stepped into the breach caused by GE Healthcare's decision to scrap its CodeLink arrays.
'Global centre of microarray excellence'
Oxford Gene Technology and Agilent are to collaborate to develop a global centre of microarray excellence focused on new and emerging applications.
Testing for HIV drug resistance
The development of a highly sensitive assay for the detection of drug-resistant HIV strains could aid our understanding of how the virus mutates, helping new drug discovery programs.
18-Jan-2007
First integrated eClinical software gets underway
Two companies have gone a step further to capture a bigger chunk of the budding eClinical market by offering a new integrated solution for pharma companies who continue to move away from paper toward electronic reporting in clinical trials.
Multi-tasking software "harmonises" regulatory affairs
US-based Blue Mountain has launched an integrated, comprehensive software package to help life sciences companies manage their assets, cutting out the need for individual software.
17-Jan-2007
Tocris Bioscience completes $40m management buy out
Tocris, a leading supplier of chemicals, peptides and antibodies to the major pharmaceutical companies, universities and research institutes has completed a $40m (€30.8m) management buy out (MBO) from its founders.
BG Medicine and Applied Biosystems collaborate on biomarker-guided drug discovery
BG Medicine will integrate Applied Biosystems' state of the art technology into its systems biology platforms to enhance its biomarker discovery and monitoring programs.
16-Jan-2007
Acoustic technology 'tops sonication' for tablet QC
The power of sound waves could aid the pharmaceutical industry in carrying out routine quality control of solid dosage forms, according to the company behind the technology.
15-Jan-2007
Military-certified EP-IR technology for use in quality control
Aspectric's industrial infrared spectroscopy analyser, recently launched into a market valued at $1.6 billion, has been granted a new US patent.
Microlaboratory unravels protein function
A high throughput microfluidic platform brings the ability to understand biological network function a step closer.
12-Jan-2007
Scientists publish 'atlas' of how proteins flex
Researchers have published an 'atlas' showing how proteins can change shape and interact with other molecules, which could prove an invaluable tool to drug developers.
PerkinElmer continues cellular growth
PerkinElmer (PE) has continued its growth in the advanced cellular sciences sector, with the completed acquisitions of Euroscreen Products and Evotec Technologies.
Predicting Proteomics
A new computer model could improve quantitative proteomics and speed up lead optimisation by predicting how a protein will break down during analysis.
11-Jan-2007
TrackWise keeps tabs on Polish pharma quality management
Drug manufacturers have moved towards centralised data and information management, following a trend to prevent human errors and time-consuming tasks in response to increasing regulatory requirements.
10-Jan-2007
Virtual clinical trial technology vindicated
The use of virtual patients to simulate clinical trials on computers can forecast their results, potentially optimising drug development and saving the pharmaceutical industry billions.
Stem cell device could have role in cancer treatment
Researchers at the University of Rochester and StemCapture have unveiled a new device technology that makes it possible to harvest stem cells from the blood, bypassing the controversial use of stem cells sourced from embryos.
Millipore's NovaSeal simplifies sterile liquid handling
Millipore has introduced a new disposable product - NovaSeal - that ties in with a shift in the bioprocess manufacturing market to the use of disposable assemblies to shorten production cycles for drugs.
09-Jan-2007
India's drug makers set for business influx
India's drug manufacturing industry is tipped to grow 10 per cent over the next three years as more pharma firms shift operations there to cut costs, says a research report.
08-Jan-2007
Ecopia and Caprion pool resources
Caprion and Ecopia have agreed to merge as equals to form an as yet unnamed public entity with three programs in cancer and infectious diseases in clinical development.
Scientists win patent for nanotech manufacturing process
US researchers have been awarded a patent for their new manufacturing technology which enables the quick and cheap production of nanoparticles used to formulate and deliver drugs - good news for NanoMed who has an exclusive licence for the technology.
05-Jan-2007
Forbes salute nanoparticle chemotherapy
Forbes has highlighted the important role of nanotechnology in driving forward the pharmaceutical industry with three of their top five nanotech breakthroughs in 2006 having biological applications.
Applied Biosystems sue Solexa for patent ownership
Applera's Applied Biosystems group has filed a law suit seeking rights to Solexa's 'sequencing-by-ligation' patents.
Fingerprinting live bacteria
A mass spectrometric (MS) technique allows rapid detection and identification of bacteria with no need for time consuming pre-treatments.
04-Jan-2007
Sartorius acquires thermoplastics firm Toha Plast
German technology group Sartorius have acquired all shares in plastics manufacturer Toha Plast.
03-Jan-2007
Tripos to dissolve after Discovery Research sale
Tripos has agreed to sell its UK-based Discovery Research business to US-based drug discovery company Provid Pharmaceuticals for $2m (€1.5m).
PerkinElmer snaps up Triton's thermal analysis line
PerkinElmer has announced its acquisition of a line of Dynamic Mechanical Analysis (DMA) products from UK-based firm Triton Technology in its latest move following a busy year of purchases during 2006.
Alzheimer's diagnostic could advance drug development
Researchers at UCLA in the USA have developed the first non-invasive diagnostic test for Alzheimer's disease.
GAO bemoans lack of new drugs
A US government report has warned that the pharmaceutical industry is not producing enough new drugs despite spending more on research and development.
LAB Research expands preclinical testing in Canada
LAB Research has completed a $12m facility expansion in Canada that will increase its preclinical testing services capacity at the site by 40 per cent.
02-Jan-2007
Smaller drug firms risk non-compliance with EU environmental guide
A number of executives and technical staff at small to medium size pharmaceutical firms are unaware of how to use their resources effectively to comply with new EMEA guidelines, designed to minimise the environmental impact of compounds, according to consultancy firm Gradient.
| « Previous month | Next month » |
© 2000/2009 - Decision News Media SAS - All right reserved.
